| Home | E-Submission | Sitemap | Contact Us |  
Cancer Research and Treatment > Volume 33(3); 2001 > Article
Cancer Research and Treatment 2001;33(3): 236-242. doi: https://doi.org/10.4143/crt.2001.33.3.236
Growth Suppression of Ovarian Cancer Cells by Interferon-gama
Jong Sup Park, Eun Joo Kim, Tae Chul Park, Eun Jung Kim, Jin Kim, Joon Mo Lee, Sung Eun Namkoong, Soo Jong Um
1Department of Obstetrics and Gynecology, The CatholicUniversity Medical College.
2Department of Anatomy, The Catholic University MedicalCollege.
3Catholic Cancer Research Institute, Catholic ResearchInstitute of Medical Science, Seoul, Korea.
4Department of Life Science, Sejong University, Seoul, Korea.
  Published online: June 30, 2001.
Growth regulation of cancer cells very frequently involves tumor suppressor gene p53, Rb and cell cycle regulator, however the molecular biologic mechanisms of growth regulation in ovarian carcinoma cells are not fully defined. To assess the mechanism of growth suppression, we treated IFN-gama in ovarian carcinoma cells.
Growth suppression by treatment of IFN-gama was determined by cell proliferation assay in ovarian carcinoma cell lines. Apoptosis was determined by DNA fragmentation assay and electron microscopy. Molecular mechanism of the apoptosis in ovarian carcinoma cell by IFN-gama was further analyzed by the western blot.
We found that IFN-gama had remarkable growth- suppressive effects in PA-1 and A2774 ovarian carcinoma cells in a time-dependent manner. Apoptosis was observed in PA-1 and A2774 cell following treatment of IFN- gama by DNA fragmentation assay and EM. The expression of IRF-1 protein from A2774 and PA-1 cell extracts was elevated by increasing the concentration of IFN-gama. IFN-gama caused an increased expression of the important apoptosis-related gene, ICE (interleukin-1beta-converting enzyme) protein in A2774 and PA-1.
The coordinate induction of IRF-1 and ICE by IFN-gama in ovarian carcinoma cells suggests a functional relationship between these proteins in programmed cell death. The significance of this study is the molecular biologic background of IFN-gama considered as an alternative treatment trial of ovarian cancers.
Key words: Ovary neoplasm;IFN-gama;Interferon regulatory factor-1;Interleukin-1 beta-converting enzyme;Apoptosis
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI